This PubMed-indexed item is a peer-reviewed review article published in Curr Hematol Malig Rep on 2026 Sep 18 (volume 21, issue 1, article 21). The article title indicates a focused update and review addressing molecular response, event-free survival, and treatment-free remission in myeloproliferative neoplasms (MPNs), and explicitly notes inclusion of insights from the MPN Asia 2026 meeting.
The PubMed record used as the source confirms the article’s existence, bibliographic metadata, and indexing identifiers, but the page content captured here did not include the article abstract or the body text. Therefore, specific review findings, data summaries, or recommendations were not reported in the source.
The review is multi-author and multi-institutional. Lead and contributing authors listed on the PubMed record include Ghaith Abu-Zeinah, Gabriela S Hobbs, Raajit K Rampal, Sung-Eun Lee, Harinder Gill, Rami Komrokji, Tsewang Tashi, Prithviraj Bose, John Mascarenhas, Abdulraheem Yacoub, Stephen T Oh, Kazuya Shimoda, Brandi N Reeves, Minghui Duan, Lennex Hsueh-Lin Yu, Albert Qin, Josef T Prchal, Kenneth Kaushansky, and Ruben A Mesa.
Affiliated institutions span academic medical centers and research institutes across North America and Asia, including but not limited to:
These affiliations reflect a broad geographic and institutional collaboration appearing on the PubMed record.
The PubMed entry provides the following identifiers and citation data for the review:
The PubMed record also includes navigation links to sections typically present on the article page (Title & authors, Abstract, Conflict of interest statement, References, Publication types, MeSH terms, Substances), though the substantive abstract was not present in the captured source content.
Based solely on the title presented in the PubMed record, the review addresses three interrelated clinical and research domains within MPN care:
Molecular response — molecular-level measures of disease burden or response to therapy in MPNs.
Event-free survival — outcome metrics related to time without disease-related events, as applied to MPN patient cohorts.
Treatment-free remission — the concept or possibility of sustained remission off therapy in patients with MPNs.
The title further indicates that the review incorporates perspectives or findings that were discussed at the MPN Asia 2026 meeting, suggesting regional meeting insights contributed to the review content.
The PubMed page used as the source confirms the article’s bibliographic metadata but did not include the abstract text or the review’s detailed content in the captured snapshot. Consequently, the source did not report specific data, results, clinical recommendations, or conclusions from the review.
Clinicians, researchers, or other readers seeking the article’s substantive content (abstract, figures, summarized evidence, and authors’ conclusions) should retrieve the full text via the DOI link, the journal’s website, or institutional access. The DOI provided (10.1007/s11899-026-00790-5) is the direct persistent identifier for locating the published review.
The PubMed record is authoritative for citation metadata and indexing. However, the captured source content did not include the review abstract or body; therefore, any assertions about study findings, quantitative outcomes, recommendations, or the nature of the MPN Asia 2026 insights cannot be drawn from this source alone.
Next steps for readers who need the substantive review content:
Note: This summary and rewrite are based exclusively on the PubMed page metadata captured as the source. The PubMed record confirms the review’s publication and authorship but did not report the article’s internal content in the provided source text.